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Abstract
Objective To determine the perception of Maltese 
community pharmacists regarding supplementary 
prescribing.
Method A self-administered questionnaire 
was developed, tested for validity and reliability and 
distributed to 50 community pharmacists selected by 
stratified random sampling. Statistical analysis was 
undertaken using Microsoft® Excel® XP and the BioMedical 
Data Package (BMDP) software.
Key Findings Cronbach’s alpha correlation 
coefficient for the questionnaire was 0.8191. Forty-six 
pharmacists responded to the questionnaire. Twenty-
three pharmacists were in favour of supplementary 
prescribing for a variety of conditions predominantly 
gastro-oesophageal reflux disease and asthma (both 19 
pharmacists). Pharmacists (20) envisaged the introduction 
of supplementary prescribing by forming liaisons with 
general practitioners. 
Conclusion The initial response to the concept 
of pharmacist prescribing is encouraging.  Community 
pharmacy in Malta will need to make changes in order to 
provide such services to patients. 
Key words supplementary prescribing, pharmacist 
perception, community pharmacy practice
Introduction
Granting prescribing rights to pharmacists is likely to 
reduce fragmentation within the health care system, 
optimise medication management, improve continuity 
of patient care and improve patient access to medication. 
Knowledge and clinical significance of adverse effects, 
dosing, optimal routes, drug-drug and drug-food 
interactions, pharmacokinetics, pharmacodynamics and 
patient monitoring is required for prescribing.1,2 
Eight models for pharmacist prescribing (Figure 1) have 
been implemented internationally (in the United Kingdom, 
the United States of America, Canada and New Zealand), 
varying in their dependency on protocols, formularies 
and collaboration with physicians.1,2  Supplementary 
prescribing involves a partnership between an 
independent prescriber, who establishes the diagnosis 
and starts treatment, and a supplementary prescriber, who 
monitors the patient and prescribes further medication, 
to implement a patient-specific clinical management plan 
with the patient’s agreement. In this scenario, independent 
prescribers are doctors or dentists and supplementary 
prescribers are pharmacists or nurses.1,2,3 
In the United Kingdom, supplementary prescribing was 
introduced in the Health and Social Care Act 20014 and 
there is no restriction on the medical conditions to which 
this model applies. However supplementary prescribing 
is unlikely to be used for acute conditions. All medicines, 
excluding controlled drugs and unlicensed medicines 
may be prescribed. Supplementary prescribing is not 
restricted to one-to-one prescriber partnerships. The 
independent prescriber undertakes the initial assessment 
and the supplementary prescriber writes prescriptions, 
working towards a care management strategy agreed by 
the physician. The roles of the supplementary prescriber 
include contributing to clinical management plan 
monitoring, changing the medication and referring to the 
independent prescriber where appropriate, and recording 
clinically relevant facts.1,2,3
The aim of this study was to determine the perception of 
Maltese community pharmacists regarding supplementary 
prescribing.
Francesca Wirth, Lilian M Azzopardi, Marise Gauci, Anthony Serracino-Inglott,  
Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida 
Corresponding author: Francesca Wirth, email: francesca.wirth@um.edu.mt
COMMUNITY PHARMACIST 
PERCEPTION OF SUPPLEMENTARY 
PRESCRIBING
JOURNAL OF EUROMED PHARMACY 
15
Method
A self-administered questionnaire was devised. It was 
divided into two sections with a total of 28 sub-divided 
questions; Section A was called ‘Pharmacy Data’, whilst 
Section B was called ‘Patient Consultation’ .
The main concept addressed was supplementary 
prescribing together with other issues including; the use 
of computer technology in the pharmacy, maintaining  of 
patient medication records, setting up of consultation 
areas, remuneration for pharmacists’ services, and 
continuing professional development.
After designing the questionnaire, psychometric 
evaluation of the tool was carried out to assess its validity 
and reliability. All data was inputted into Microsoft® 
Excel® XP and statistical analysis was carried out using 
the BioMedical Data Package (BMDP) software, where 
internal consistency was measured using Cronbach’s alpha 
correlation coefficient. 
The sampling frame consisted of 211 community 
pharmacies (subdivided into 5 districts according to the 
National Statistics Office demographic data) from which 10 
pharmacies were selected from each district by stratified 
random sampling. A total of 50 copies of the questionnaire 
were personally distributed by the investigator (FW) to 
community pharmacists practising in the 50 identified 
pharmacies.
Results
RElIABIlITy OF THE QUEsTIONNAIRE
Cronbach’s alpha correlation coefficient was 0.8191 
indicating high reliability of the questionnaire.
DEsCRIBINg THE sAMPlE
Forty-six pharmacists responded to the questionnaire 
giving a response rate of 92%. Thirty-four were managing 
pharmacists, 20 were aged between 30 and 39 year and 30 
were females. Twenty-eight pharmacists were owners of 
the pharmacy. 
PHARMACIsT PERCEPTION
Twenty-three pharmacists were in favour of 
supplementary prescribing. Pharmacists accepted 
supplementary prescribing, predominantly for chronic 
conditions namely gastro-oesophageal reflux disease 
and asthma (both 19 pharmacists), hypertension (18 
pharmacists) and diabetes (14 pharmacists). Pharmacists 
were most reluctant to accept supplementary prescribing 
for long-term anticoagulant therapy (2 pharmacists). 
‘Other’ conditions included minor infections such as upper 
respiratory tract infections and skin conditions (Figure 2). 
Pharmacists envisaged the development of supplementary 
prescribing locally mainly by forming liaisons with general 
practitioners (20 pharmacists) and by keeping records of 
interventions (12 pharmacists) (Figure 3).
BARRIERs
Many barriers for the implementation of supplementary 
prescribing were identified, principally the lack of 
specialised training and continuing professional 
development (16 pharmacists), the fact that patients 
would still refer back to his or the general practitioner (15 
pharmacists) and no access to patient medication records 
(11 pharmacists) (Figure 4). 
CONTINUINg PROFEssIONAl DEVElOPMENT (CPD)
Thirty one out of the 46 pharmacists interviewed felt that 
they did not possess sufficient knowledge to carry out 
consultations such as supplementary prescribing and  42 
out of the 46 pharmacists were willing to participate in 
programmes for professional development in the area.
COMPUTERIsATION AND PATIENT MEDICATION 
RECORDs (PMRs) 
A majority of 44 out of 46 pharmacists did not maintain 
patient medication records (PMRs). Thirty seven 
pharmacists stated that the main reason for not keeping 
PMRs is that patients did not always buy medications 
from the same pharmacy, resulting in incomplete records. 
Other limitations were that many patients collected free 
medications from government-owned pharmacies (26 
pharmacists), time constraints (28 pharmacists), increased 
workload for the pharmacist (24 pharmacists), and the cost 
of installing the computer system and the PMR program (6 
pharmacists).
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A computer system was installed in 18 out of the 46 
pharmacies. Pharmacists used the computer for pharmacy 
management (14 pharmacists), for point-of-sale purposes 
(12 pharmacists), for labelling (3 pharmacists) and to aid 
pharmaceutical advice (1 pharmacist). One pharmacy used 
the computer to maintain PMRs. Ten pharmacists from the 
28 pharmacies without a computer system considered lack 
of space as the main limitation. Nine pharmacists felt that 
a computer was unnecessary, 7 pharmacists perceived cost 
issues to be a limitation and 4 pharmacists were computer 
illiterate.
CONsUlTATION AREAs
Only twelve out of the 46 pharmacists had an area 
available for consultations. The main limitation for setting 
up a consultation area was lack of space (32 pharmacists). 
The need to employ another pharmacist and/or additional 
pharmacy personnel to cover for the pharmacist whilst 
s/he is carrying out a consultation was perceived to be 
another important limitation by 18 pharmacists. Forty one 
out of the 46 pharmacies had one pharmacist on duty in 
the pharmacy at any time and only 11 of these were willing 
to employ other personnel. Twenty two pharmacies out of 
the 46 had no salespersons employed in the pharmacy.
CONsUlTATION FEEs
Thirty nine out of the 46 pharmacists would consider 
charging a fee for carrying out consultations. Nineteen 
of these pharmacists would charge 1.16 or 2.33 euro per 
consultation, whilst 1 pharmacist would charge 4.66 euro. 
None of the pharmacists interviewed would charge more 
than 4.66 euro.
Discussion
The initial response from community pharmacists towards 
pharmacist prescribing is encouraging. Half (11 out of 22) 
of the pharmacists who were against the introduction 
of supplementary prescribing perceived the lack of 
patient medication records as a barrier. Fifty- four percent 
(12 out of 23) of the pharmacists envisaged the local 
implementation of supplementary prescribing only if the 
pharmacist keeps records of interventions carried out, 
together with other information that may be used for that 
patient if the need arises in the future.
Computer technology will make the recording of 
pharmacist interventions and prescriptions less time-
consuming and the storage and access of patient histories 
more reliable. Maintenance of patient records is also 
required for pharmacist prescribing. The system should 
be effective and may require transfer of information back 
to the medical practitioner. For pharmacists to be able to 
prescribe any medication and to provide the best possible 
care, all medical information concerning the patient must 
be collected.5,6
Pharmacies are now installing a computer system due to 
the introduction of the Pharmacy Of Your Choice (POYC) 
scheme. This computer system should be able to be 
adapted to facilitate the maintenance of patient records 
which are essential for supplementary prescribing. 
A consultation area is described as a clearly designated 
area for confidential consultations. It must be an area 
where the pharmacist and patient can talk at normal 
speaking volumes without being overheard by other 
clients or by staff.7 Consultation areas are a prerequisite 
for pharmacist prescribing. Community pharmacies in 
Malta are small, therefore the main difficulty with setting 
up consultation areas is lack of space. Areas within the 
pharmacy which provide privacy could be created.
Securing remuneration for professional responsibility 
is another step in the adoption of prescribing rights. 
Changes to the roles of the current workforce may be 
needed as a result of offering pharmacist prescribing. If 
a pharmacist is engaged in a private conversation with a 
patient, mechanisms need to be put in place to ensure the 
rest of the work continues. This may involve employing 
another pharmacist. 
Training is also necessary. Pharmacists who wish to 
become prescribers  may be offered optional life-
long learning programmes which they could follow. 
There may be resistance to change from within the 
pharmacy profession, and other professions may feel 
that prescribing pharmacists intrude on their area of 
professional responsibility. The development of collegial 
working relationships is essential in the acceptance of new 
prescribers. The success of pharmacist prescribing will be 
determined by the ability of pharmacists and doctors to 
work as a team.
Conclusion
The barriers for the implementation of supplementary 
prescribing include computerisation, lack of access to 
patient records, lack of space for consultation, and lack 
of pharmacist motivation. The implementation of a fee 
for professional services provided could be an incentive 
to promote supplementary prescribing. The success of 
pharmacist prescribing is determined by the ability of 
pharmacists and other prescibers to work as a team. 
In the United Kingdom the issue of pharmacist prescribing 
has moved a step further. In November 2005 it was 
announced that pharmacists in the United Kingdom will 
have powers to independently prescribe medicines. This 
means that pharmacists were given the right to prescribe 
any licensed medicine for any condition within their 
competence, with the exception of Controlled Drugs.8
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of supplementary 
prescribing include 
computerisation, 
lack of access to 
patient records, 
lack of space for 
consultation, and 
lack of pharmacist 
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Figure 1: Models for pharmacist prescribing 
(adopted from Emmerton L, Marriot J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of 
international developments. J Pharm Pharmaceut Sci [serial on the Internet]. 2005 Aug [cited 2009 Mar 25];8(2):[9 p.] 
Available from: www.ualberta.ca/~csps/JPPS8(2)/L.Emmerton/pharmacists.pdf)
Figure 2: Conditions for which pharmacists accepted supplementary prescribing (n=23)
COPD = Chronic Obstructive Pulmonary Disease; HRT = Hormone Replacement Therapy; GORD = Gastro-Oesophageal 
Reflux Disease
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Figure 3: How pharmacists envisage the implementation of supplementary prescribing (n=23)
GP = General Practitioner
Figure 4: Barriers for the introduction of supplementary prescribing (n=22)
CPD = Continuing Professional Development; PMRs = Patient Medication Records; GP = General Practitioner 
